Cytosorbents Corp
CTSO
37 hedge funds and large institutions have $11.1M invested in Cytosorbents Corp in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
27% more capital invested
Capital invested by funds: $8.69M → $11.1M (+$2.37M)
3.35% more ownership
Funds ownership: 6.26% → 9.62% (+3.4%)
3% less funds holding
Funds holding: 38 → 37 (-1)
54% less call options, than puts
Call options by funds: $112K | Put options by funds: $244K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.64M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.23M |
| 3 |
Millennium Management
New York
|
+$895K |
| 4 |
BlackRock
New York
|
+$664K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$587K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$224K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$94K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$70.8K |
| 4 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
-$67.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$50.6K |
CTSO Hedge Fund Activity: Q1 2017 in Review
37 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2017, worth a combined $11.1M — up 27% from $8.69M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CTSO positions and 2 closed out — a net gain of 4 holders — while 15 added to existing stakes and 11 trimmed.
The largest buyer was Skylands Capital, adding an estimated $1.64M. The largest seller was Raymond James & Associates, cutting an estimated $224K.
- 37 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2017, down from 38 in Q4 2016.
- Funds reported $11.1M of Cytosorbents Corp stock for Q1 2017, up 27% quarter-over-quarter.
- 6 funds opened new Cytosorbents Corp positions in Q1 2017 and 2 closed out, a net change of +4 holders.
- The largest Cytosorbents Corp buyer in Q1 2017 was Skylands Capital, an estimated $1.64M added.
- The largest Cytosorbents Corp seller in Q1 2017 was Raymond James & Associates, an estimated $224K sold.
Based on aggregated 13F filings for Q1 2017.